Rkl Wealth Management LLC Pfizer Inc Transaction History

Rkl Wealth Management LLC

$1.06 Billion
Q1 2025

A detailed history of Rkl Wealth Management LLC transactions in Pfizer Inc stock. As of the latest transaction made, Rkl Wealth Management LLC holds 14,888 shares of PFE stock, worth $356,865. This represents 0.04% of its overall portfolio holdings.

Number of Shares

14,888

Previous 21,534 30.86%

Holding current value

$356,865

Previous $571,000 33.98%

% of portfolio

0.04%

Previous 0.05%

32 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2025 Apr 25, 2025	SELL	$25.01 - $27.13 $166,216 - $180,305	-6,646 Reduced 30.86%	14,888 $377,000
Q4 2024 Feb 06, 2025	BUY	$24.8 - $30.19 $157,232 - $191,404	6,340 Added 41.73%	21,534 $571,000
Q3 2024 Nov 01, 2024	SELL	$27.7 - $31.39 $11,329 - $12,838	-409 Reduced 2.62%	15,194 $439,000
Q2 2024 Jul 17, 2024	SELL	$25.26 - $29.6 $17,707 - $20,749	-701 Reduced 4.3%	15,603 $436,000
Q1 2024 May 08, 2024	SELL	$25.89 - $29.73 $11,417 - $13,110	-441 Reduced 2.63%	16,304 $452,000
Q4 2023 Jan 24, 2024	BUY	$26.13 - $33.94 $199,946 - $259,708	7,652 Added 84.15%	16,745 $482,000
Q3 2023 Nov 03, 2023	SELL	$32.09 - $37.51 $120,433 - $140,775	-3,753 Reduced 29.22%	9,093 $301,000
Q2 2023 Aug 07, 2023	BUY	$36.12 - $41.79 $1,805 - $2,089	50 Added 0.39%	12,846 $471,000
Q1 2023 May 01, 2023	SELL	$39.39 - $51.28 $65,151 - $84,817	-1,654 Reduced 11.45%	12,796 $522,000
Q4 2022 Feb 06, 2023	BUY	$41.75 - $54.5 $10,228 - $13,352	245 Added 1.72%	14,450 $740,000
Q3 2022 Nov 10, 2022	SELL	$43.76 - $53.42 $3,500 - $4,273	-80 Reduced 0.56%	14,205 $622,000
Q2 2022 Aug 01, 2022	BUY	$46.53 - $55.17 $15,727 - $18,647	338 Added 2.42%	14,285 $749,000
Q1 2022 May 10, 2022	BUY	$45.75 - $56.69 $16,195 - $20,068	354 Added 2.6%	13,947 $722,000
Q4 2021 Feb 08, 2022	BUY	$41.32 - $61.25 $25,411 - $37,668	615 Added 4.74%	13,593 $803,000
Q3 2021 Nov 15, 2021	SELL	$39.25 - $50.42 $6,005 - $7,714	-153 Reduced 1.17%	12,978 $558,000
Q2 2021 Aug 13, 2021	BUY	$35.91 - $40.68 $96,561 - $109,388	2,689 Added 25.75%	13,131 $514,000
Q1 2021 May 10, 2021	SELL	$33.49 - $37.77 $38,413 - $43,322	-1,147 Reduced 9.9%	10,442 $378,000
Q4 2020 Feb 11, 2021	SELL	$33.47 - $42.56 $77,282 - $98,271	-2,309 Reduced 16.61%	11,589 $427,000
Q3 2020 Nov 09, 2020	BUY	$31.75 - $37.25 $60,483 - $70,961	1,905 Added 15.88%	13,898 $510,000
Q2 2020 Aug 07, 2020	SELL	$30.12 - $36.54 $25,180 - $30,547	-836 Reduced 6.52%	11,993 $392,000
Q1 2020 Apr 28, 2020	SELL	$27.03 - $38.62 $11,190 - $15,988	-414 Reduced 3.13%	12,829 $419,000
Q4 2019 Feb 04, 2020	BUY	$32.92 - $37.36 $5,859 - $6,650	178 Added 1.36%	13,243 $519,000
Q3 2019 Oct 31, 2019	SELL	$32.49 - $42.13 $43,179 - $55,990	-1,329 Reduced 9.23%	13,065 $472,000
Q2 2019 Aug 02, 2019	BUY	$36.98 - $41.52 $78,619 - $88,271	2,126 Added 17.33%	14,394 $622,000
Q1 2019 Apr 26, 2019	SELL	$37.5 - $41.2 $11,025 - $12,112	-294 Reduced 2.34%	12,268 $521,000
Q4 2018 Feb 08, 2019	SELL	$38.47 - $43.86 $61,667 - $70,307	-1,603 Reduced 11.32%	12,562 $546,000
Q3 2018 Nov 07, 2018	SELL	$34.47 - $41.81 $61,770 - $74,923	-1,792 Reduced 11.23%	14,165 $622,000
Q2 2018 Aug 03, 2018	SELL	$32.98 - $35.16 $125,323 - $133,608	-3,800 Reduced 19.23%	15,957 $583,000
Q1 2018 Apr 26, 2018	SELL	$31.91 - $37.02 $72,308 - $83,887	-2,266 Reduced 10.29%	19,757 $701,000
Q4 2017 Feb 02, 2018	SELL	$33.26 - $35.29 $230,924 - $245,018	-6,943 Reduced 23.97%	22,023 $801,000
Q3 2017 Nov 07, 2017	SELL	$31.0 - $34.15 $138,725 - $152,821	-4,475 Reduced 13.38%	28,966 $1.03 Million
Q2 2017 Aug 14, 2017	BUY	N/A	33,441	33,441 $1.13 Million

Others Institutions Holding PFE

# of Institutions

3,370

Shares Held

3.61B

Call Options Held

102M

Put Options Held

130M

View Full List

About PFIZER INC

Ticker PFE
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 5,612,349,952
Market Cap $135B
Description
Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...

More about PFE

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Rkl Wealth Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Rkl Wealth Management LLC with notifications on news.

Account

Rkl Wealth Management LLC Pfizer Inc Transaction History